Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer

Prostate cancer is the second major cause of male cancer deaths. Obesity, type 2 diabetes, and cancer risk are linked. Insulin-like growth factor II (IGF-II) is involved in numerous cellular events, including proliferation and survival. The IGF-II gene shares its locus with the lncRNA, H19. IGF-II/H...

Full description

Bibliographic Details
Main Authors: Georgina Kingshott, Kalina Biernacka, Alex Sewell, Paida Gwiti, Rachel Barker, Hanna Zielinska, Amanda Gilkes, Kathryn McCarthy, Richard M. Martin, J. Athene Lane, Lucy McGeagh, Anthony Koupparis, Edward Rowe, Jon Oxley, Jeff M. P. Holly, Claire M. Perks
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
H19
Online Access:https://www.mdpi.com/2072-6694/13/4/825
id doaj-4c8db63ee1144af2b88c2c73be734184
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Georgina Kingshott
Kalina Biernacka
Alex Sewell
Paida Gwiti
Rachel Barker
Hanna Zielinska
Amanda Gilkes
Kathryn McCarthy
Richard M. Martin
J. Athene Lane
Lucy McGeagh
Anthony Koupparis
Edward Rowe
Jon Oxley
Jeff M. P. Holly
Claire M. Perks
spellingShingle Georgina Kingshott
Kalina Biernacka
Alex Sewell
Paida Gwiti
Rachel Barker
Hanna Zielinska
Amanda Gilkes
Kathryn McCarthy
Richard M. Martin
J. Athene Lane
Lucy McGeagh
Anthony Koupparis
Edward Rowe
Jon Oxley
Jeff M. P. Holly
Claire M. Perks
Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer
Cancers
IGF2
H19
imprinting
cancer
inflammatory markers
author_facet Georgina Kingshott
Kalina Biernacka
Alex Sewell
Paida Gwiti
Rachel Barker
Hanna Zielinska
Amanda Gilkes
Kathryn McCarthy
Richard M. Martin
J. Athene Lane
Lucy McGeagh
Anthony Koupparis
Edward Rowe
Jon Oxley
Jeff M. P. Holly
Claire M. Perks
author_sort Georgina Kingshott
title Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer
title_short Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer
title_full Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer
title_fullStr Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer
title_full_unstemmed Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer
title_sort alteration of metabolic conditions impacts the regulation of igf-ii/h19 imprinting status in prostate cancer
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2021-02-01
description Prostate cancer is the second major cause of male cancer deaths. Obesity, type 2 diabetes, and cancer risk are linked. Insulin-like growth factor II (IGF-II) is involved in numerous cellular events, including proliferation and survival. The IGF-II gene shares its locus with the lncRNA, H19. IGF-II/H19 was the first gene to be identified as being “imprinted”—where the paternal copy is not transcribed—a silencing phenomenon lost in many cancer types. We disrupted imprinting behaviour in vitro by altering metabolic conditions and quantified it using RFLP, qPCR and pyrosequencing; changes to peptide were measured using RIA. Prostate tissue samples were analysed using ddPCR, pyrosequencing and IHC. We compared with in silico data, provided by TGCA on the cBIO Portal. We observed disruption of imprinting behaviour, in vitro<i>,</i> with a significant increase in IGF-II and a reciprocal decrease in H19 mRNA; the increased mRNA was not translated into peptides. In vivo, most specimens retained imprinting status apart from a small subset which showed reduced imprinting. A positive correlation was seen between IGF-II and H19 mRNA expression, which concurred with findings of larger Cancer Genome Atlas (TGCA) cohorts. This positive correlation did not affect IGF-II peptide. Our findings show that type 2 diabetes and/or obesity, can directly affect regulation growth factors involved in carcinogenesis, indirectly suggesting a modification of lifestyle habits may reduce cancer risk.
topic IGF2
H19
imprinting
cancer
inflammatory markers
url https://www.mdpi.com/2072-6694/13/4/825
work_keys_str_mv AT georginakingshott alterationofmetabolicconditionsimpactstheregulationofigfiih19imprintingstatusinprostatecancer
AT kalinabiernacka alterationofmetabolicconditionsimpactstheregulationofigfiih19imprintingstatusinprostatecancer
AT alexsewell alterationofmetabolicconditionsimpactstheregulationofigfiih19imprintingstatusinprostatecancer
AT paidagwiti alterationofmetabolicconditionsimpactstheregulationofigfiih19imprintingstatusinprostatecancer
AT rachelbarker alterationofmetabolicconditionsimpactstheregulationofigfiih19imprintingstatusinprostatecancer
AT hannazielinska alterationofmetabolicconditionsimpactstheregulationofigfiih19imprintingstatusinprostatecancer
AT amandagilkes alterationofmetabolicconditionsimpactstheregulationofigfiih19imprintingstatusinprostatecancer
AT kathrynmccarthy alterationofmetabolicconditionsimpactstheregulationofigfiih19imprintingstatusinprostatecancer
AT richardmmartin alterationofmetabolicconditionsimpactstheregulationofigfiih19imprintingstatusinprostatecancer
AT jathenelane alterationofmetabolicconditionsimpactstheregulationofigfiih19imprintingstatusinprostatecancer
AT lucymcgeagh alterationofmetabolicconditionsimpactstheregulationofigfiih19imprintingstatusinprostatecancer
AT anthonykoupparis alterationofmetabolicconditionsimpactstheregulationofigfiih19imprintingstatusinprostatecancer
AT edwardrowe alterationofmetabolicconditionsimpactstheregulationofigfiih19imprintingstatusinprostatecancer
AT jonoxley alterationofmetabolicconditionsimpactstheregulationofigfiih19imprintingstatusinprostatecancer
AT jeffmpholly alterationofmetabolicconditionsimpactstheregulationofigfiih19imprintingstatusinprostatecancer
AT clairemperks alterationofmetabolicconditionsimpactstheregulationofigfiih19imprintingstatusinprostatecancer
_version_ 1724265889379909632
spelling doaj-4c8db63ee1144af2b88c2c73be7341842021-02-17T00:02:41ZengMDPI AGCancers2072-66942021-02-011382582510.3390/cancers13040825Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate CancerGeorgina Kingshott0Kalina Biernacka1Alex Sewell2Paida Gwiti3Rachel Barker4Hanna Zielinska5Amanda Gilkes6Kathryn McCarthy7Richard M. Martin8J. Athene Lane9Lucy McGeagh10Anthony Koupparis11Edward Rowe12Jon Oxley13Jeff M. P. Holly14Claire M. Perks15IGF & Metabolic Endocrinology Group, Translational Health Sciences, Bristol Medical School, Learning & Research Building, Southmead Hospital, Bristol BS10 5NB, UKIGF & Metabolic Endocrinology Group, Translational Health Sciences, Bristol Medical School, Learning & Research Building, Southmead Hospital, Bristol BS10 5NB, UKDepartment of Cellular Pathology, North Bristol NHS Trust, Southmead Hospital, Bristol BS10 5NB, UKDepartment of Cellular Pathology, North Bristol NHS Trust, Southmead Hospital, Bristol BS10 5NB, UKIGF & Metabolic Endocrinology Group, Translational Health Sciences, Bristol Medical School, Learning & Research Building, Southmead Hospital, Bristol BS10 5NB, UKIGF & Metabolic Endocrinology Group, Translational Health Sciences, Bristol Medical School, Learning & Research Building, Southmead Hospital, Bristol BS10 5NB, UKDepartment of Haematology, Cardiff University, Heath Park, Cardiff CF14 4XN, UKDepartment of Surgery, Department of Medicine, Southmead Hospital, Bristol BS10 5NB, UKPopulation Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UKBristol Randomised Trials Collaboration, Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UKSupportive Cancer Care Research Group, Faculty of Health and Life Sciences, Oxford Institute of Nursing, Midwifery and Allied Health Research, Oxford Brookes University, Jack Straws Lane, Marston, Oxford OX3 0FL, UKDepartment of Urology, Bristol Urological Institute, Southmead Hospital, Bristol BS10 5NB, UKDepartment of Urology, Bristol Urological Institute, Southmead Hospital, Bristol BS10 5NB, UKDepartment of Cellular Pathology, North Bristol NHS Trust, Southmead Hospital, Bristol BS10 5NB, UKIGF & Metabolic Endocrinology Group, Translational Health Sciences, Bristol Medical School, Learning & Research Building, Southmead Hospital, Bristol BS10 5NB, UKIGF & Metabolic Endocrinology Group, Translational Health Sciences, Bristol Medical School, Learning & Research Building, Southmead Hospital, Bristol BS10 5NB, UKProstate cancer is the second major cause of male cancer deaths. Obesity, type 2 diabetes, and cancer risk are linked. Insulin-like growth factor II (IGF-II) is involved in numerous cellular events, including proliferation and survival. The IGF-II gene shares its locus with the lncRNA, H19. IGF-II/H19 was the first gene to be identified as being “imprinted”—where the paternal copy is not transcribed—a silencing phenomenon lost in many cancer types. We disrupted imprinting behaviour in vitro by altering metabolic conditions and quantified it using RFLP, qPCR and pyrosequencing; changes to peptide were measured using RIA. Prostate tissue samples were analysed using ddPCR, pyrosequencing and IHC. We compared with in silico data, provided by TGCA on the cBIO Portal. We observed disruption of imprinting behaviour, in vitro<i>,</i> with a significant increase in IGF-II and a reciprocal decrease in H19 mRNA; the increased mRNA was not translated into peptides. In vivo, most specimens retained imprinting status apart from a small subset which showed reduced imprinting. A positive correlation was seen between IGF-II and H19 mRNA expression, which concurred with findings of larger Cancer Genome Atlas (TGCA) cohorts. This positive correlation did not affect IGF-II peptide. Our findings show that type 2 diabetes and/or obesity, can directly affect regulation growth factors involved in carcinogenesis, indirectly suggesting a modification of lifestyle habits may reduce cancer risk.https://www.mdpi.com/2072-6694/13/4/825IGF2H19imprintingcancerinflammatory markers